Alves P, Nozais V, Hansen J, Corbetta M, Nachev P, Martins I
Nat Commun. 2025; 16(1):2555.
PMID: 40089467
DOI: 10.1038/s41467-025-57680-2.
Kaye A, Islam R, Castine A, Wester G, Barham W, Nguyen C
Cureus. 2025; 17(2):e78731.
PMID: 40065888
PMC: 11892542.
DOI: 10.7759/cureus.78731.
Nakatsuka D, Suwa T, Deguchi Y, Fujita Y, Tashima R, Ohnami S
Transl Psychiatry. 2025; 15(1):77.
PMID: 40057507
PMC: 11890785.
DOI: 10.1038/s41398-025-03284-9.
Dybowski F, Scott D, Tamminga C
Neuropsychopharmacology. 2025; .
PMID: 40016366
DOI: 10.1038/s41386-025-02077-4.
Vieira S, Baecker L, Pinaya W, Garcia-Dias R, Scarpazza C, Calhoun V
Transl Psychiatry. 2025; 15(1):69.
PMID: 40016187
PMC: 11868583.
DOI: 10.1038/s41398-025-03290-x.
Cellular-Resolution and Bulk-Fluorescence Recordings of Calcium Activity Yield Reciprocal Readouts of In Vivo Drug Efficacy.
Yun S, Parker J
Synapse. 2025; 79(2):e70011.
PMID: 40013455
PMC: 11866263.
DOI: 10.1002/syn.70011.
Striatal arbitration between choice strategies guides few-shot adaptation.
Yang M, Jung M, Lee S
Nat Commun. 2025; 16(1):1811.
PMID: 39979316
PMC: 11842591.
DOI: 10.1038/s41467-025-57049-5.
Transcriptomic profiles link corticostriatal microarchitecture to genetics of neurodevelopment and neuropsychiatric risks.
Hu S, Wang Y, Wang X, Ji Y, Li C, Qiu B
Transl Psychiatry. 2025; 15(1):48.
PMID: 39934135
PMC: 11814317.
DOI: 10.1038/s41398-025-03260-3.
Corticolimbic circuitry as a druggable target in schizophrenia spectrum disorders: a narrative review.
Gee A, Dazzan P, Grace A, Modinos G
Transl Psychiatry. 2025; 15(1):21.
PMID: 39856031
PMC: 11760974.
DOI: 10.1038/s41398-024-03221-2.
Causal associations between iron levels in subcortical brain regions and psychiatric disorders: a Mendelian randomization study.
Du W, Tang B, Liu S, Zhang W, Lui S
Transl Psychiatry. 2025; 15(1):19.
PMID: 39843424
PMC: 11754438.
DOI: 10.1038/s41398-025-03231-8.
Control of striatal circuit development by the chromatin regulator .
Choi K, Henderson N, Feierman E, Louzon S, Galanaugh J, Davatolhagh F
Sci Adv. 2025; 11(3):eadq6663.
PMID: 39823338
PMC: 11740973.
DOI: 10.1126/sciadv.adq6663.
Negative Symptoms in Schizophrenia: An Update on Research Assessment and the Current and Upcoming Treatment Landscape.
Govil P, Kantrowitz J
CNS Drugs. 2025; 39(3):243-262.
PMID: 39799532
DOI: 10.1007/s40263-024-01151-7.
Schizophrenia-related Xpo7 haploinsufficiency leads to behavioral and nuclear transport pathologies.
Toyoda S, Kikuchi M, Abe Y, Tashiro K, Handa T, Katayama S
EMBO Rep. 2025; 26(4):948-981.
PMID: 39774335
PMC: 11850608.
DOI: 10.1038/s44319-024-00362-9.
Compromising Tyrosine Hydroxylase Function Extends and Blunts the Temporal Profile of Reinforcement by Dopamine Neurons in .
Amin F, Konig C, Zhang J, Kalinichenko L, Konigsmann S, Brunsberg V
J Neurosci. 2025; 45(11).
PMID: 39753299
PMC: 11905344.
DOI: 10.1523/JNEUROSCI.1498-24.2024.
An ultra low frequency spike timing dependent plasticity based approach for reducing alcohol drinking.
Asp A, Boschen S, Chang S, Kim J, Silvernail J, Lujan J
Sci Rep. 2024; 14(1):30907.
PMID: 39730615
PMC: 11680995.
DOI: 10.1038/s41598-024-81390-2.
Study on the age-period-cohort effects of cognitive abilities among older Chinese adults based on the cognitive reserve hypothesis.
Yang Q, Yu T
BMC Geriatr. 2024; 24(1):992.
PMID: 39633278
PMC: 11616311.
DOI: 10.1186/s12877-024-05576-z.
Synaptotagmin-11 deficiency mediates schizophrenia-like behaviors in mice via dopamine over-transmission.
Chen Y, Gu Y, Wang B, Wei A, Dong N, Jiang Y
Nat Commun. 2024; 15(1):10571.
PMID: 39632880
PMC: 11618495.
DOI: 10.1038/s41467-024-54604-4.
EANM perspective on clinical PET and SPECT imaging in schizophrenia-spectrum disorders: a systematic review of longitudinal studies.
Rogeau A, Boer A, Guedj E, Sala A, Sommer I, Veronese M
Eur J Nucl Med Mol Imaging. 2024; 52(3):876-899.
PMID: 39576337
PMC: 11754335.
DOI: 10.1007/s00259-024-06987-1.
Brain metabolic profiling of schizophrenia: a path towards a better understanding of the neuropathogenesis of psychosis.
Rossetti M, Stanca S, Panichi L, Bongioanni P
Metab Brain Dis. 2024; 40(1):28.
PMID: 39570439
DOI: 10.1007/s11011-024-01447-z.
Functional Connectivity Biomarkers in Schizophrenia.
Howell A, Anticevic A
Adv Neurobiol. 2024; 40:237-283.
PMID: 39562448
DOI: 10.1007/978-3-031-69491-2_10.